What are the contemporary management patterns and guideline compliance for atrial fibrillation in ESC member countries?
Baseline results from the EORP-AF Pilot Registry demonstrate that despite increased overall oral anticoagulant use, novel OAC uptake is low and guideline adherence remains suboptimal.
The EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry has provided systematic collection of contemporary data regarding the management and treatment of AF by cardiologists in ESC member countries. Oral anticoagulant use has increased, but novel OAC use was still low. Compliance with the treatment guidelines for patients with the lowest and higher stroke risk scores remains suboptimal.
Lip et al. (Tue,) studied this question.